Dorota Rowczenio

9.3k citations

86 papers · 3.8k indexed · 1 hit paper · h-index 33

Molecular Biology top 2%
Nephrology top 0.5%
Oncology top 5%
Rheumatology top 1%
Cardiology and Cardiovascular Medicine top 5%

Co-authors: Philip N. Hawkins Helen J. Lachmann Julian D. Gillmore Janet A. Gilbertson Ashutosh Wechalekar Carol Whelan Marianna Fontana Simon Gibbs
Topics: Amyloidosis: Diagnosis, Treatment, Outcomes (59 papers)Inflammasome and immune disorders (24 papers)Parathyroid Disorders and Treatments (21 papers)
Cited by: Nephrology Molecular Biology Rheumatology
Journals: Journal of Clinical Oncology Blood Gastroenterology
Partner nations: United Kingdom United States Italy

In The Last Decade

Dorota Rowczenio

81 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new staging system for cardiac transthyretin amyloidosis

2017 453 citations Julian D. Gillmore, Marianna Fontana et al. profile →

Peers

Countries citing papers authored by Dorota Rowczenio

Since Specialization

Citations

This map shows the geographic impact of Dorota Rowczenio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorota Rowczenio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorota Rowczenio more than expected).

Fields of papers citing papers by Dorota Rowczenio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorota Rowczenio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorota Rowczenio. The network helps show where Dorota Rowczenio may publish in the future.

Co-authorship network of co-authors of Dorota Rowczenio

This figure shows the co-authorship network connecting the top 25 collaborators of Dorota Rowczenio. A scholar is included among the top collaborators of Dorota Rowczenio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorota Rowczenio. Dorota Rowczenio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mapping VEXAS ‐associated and rare UBA1 variants in the United Kingdom : Insights from patient cohorts and the general population 2025 ·British Journal of Haematology ·A. Rodríguez,(unknown),Dorota Rowczenio,Alexandra Smith,Ebun Omoyinmi,James A. Poulter,Andrew McGregor,Sebastian Francis,(unknown),(unknown),Kar Lok Kong,David G. Kent,Helen J. Lachmann,Austin Kulasekararaj,Catherine Cargo,Sinisa Savic	2
2	OP0323 CAUSES OF AA AMYLOIDOSIS: ANALYSIS OF 952 PATIENTS SEEN AT A REFERENCE CENTRE OVER 34 YEARS 2024 ·Annals of the Rheumatic Diseases ·Helen J. Lachmann,Oliver Cohen,Marianna Fontana,Janet A. Gilbertson,Julian D. Gillmore,Philip N. Hawkins,S. Mahmood,(unknown),(unknown),Sriram Ravichandran,Dorota Rowczenio,Ashutosh Wechalekar,Carol Whelan	1
3	Genetic Approaches to Study Rheumatic Diseases and Its Implications in Clinical Practice 2024 ·Arthritis & Rheumatology ·Dorota Rowczenio,Ivona Aksentijevich	4
4	Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy 2021 ·Heart ·Steven Law,Aviva Petrie,Liza Chacko,Oliver Cohen,Sriram Ravichandran,Janet A. Gilbertson,Dorota Rowczenio,Ashutosh Wechalekar,Ana Martinez–Naharro,Helen J. Lachmann,Carol Whelan,David F. Hutt,Philip N. Hawkins,Marianna Fontana,Julian D. Gillmore	20
5	A Novel Pathogenic NOD2 Variant in a Mother and Daughter with Blau Syndrome 2021 ·Ophthalmic Genetics ·(unknown),Harry Petrushkin,Andrew R. Webster,(unknown),Elena Moraitis,Dorota Rowczenio,Juan I. Aróstegui,Mark Westcott	3
6	Clinical ApoA‐IV amyloid is associated with fibrillogenic signal sequence 2021 ·The Journal of Pathology ·Diana Canetti,(unknown),Nigel B. Rendell,(unknown),Janet A. Gilbertson,Angel I. Blanco,Dorota Rowczenio,Alessandra Morelli,P. Patrizia Mangione,Alessandra Corazza,Guglielmo Verona,Sofia Giorgetti,Loredana Marchese,Per Westermark,Philip N. Hawkins,Julian D. Gillmore,(unknown),Graham W. Taylor	8
7	Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report 2021 ·Pediatric Rheumatology ·Ebun Omoyinmi,Dorota Rowczenio,Neil J. Sebire,Paul Brogan,Despina Eleftheriou	2
8	Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression 2020 ·JACC. Cardiovascular imaging ·Marianna Fontana,Ana Martinez–Naharro,Liza Chacko,Dorota Rowczenio,Janet A. Gilbertson,Carol Whelan,(unknown),Thirusha Lane,James Moon,David F. Hutt,Peter Kellman,Aviva Petrie,Philip N. Hawkins,Julian D. Gillmore	128
9	British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature 2019 ·Lara D. Veeken ·Dorota Rowczenio,Taryn Youngstein,Hadija Trojer,Ebun Omoyinmi,Anna Baginska,Paul Brogan,Charalampia Papadopoulou,Tamer Rezk,Philip N. Hawkins,Helen J. Lachmann	14
10	Current practices for the genetic diagnosis of autoinflammatory diseases: results of a European Molecular Genetics Quality Network Survey 2019 ·European Journal of Human Genetics ·Dorota Rowczenio,Yael Shinar,Isabella Ceccherini,(unknown),Mariëlle van Gijn,Simon Patton,Isabelle Touitou	7
11	International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors 2017 ·Lara D. Veeken ·Taryn Youngstein,Patrycja Hoffmann,Ahmet Gül,Thirusha Lane,René M. Williams,Dorota Rowczenio,Huri Özdoğan,Serdal Uğurlu,John Ryan,(unknown),Sean Riminton,(unknown),Joachim Roesler,Norbert Blank,Jasmin Kuemmerle‐Deschner,Anna Simon,Adrian S. Woolf,Philip N. Hawkins,Helen J. Lachmann	88
12	Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein 2016 ·Kidney International Reports ·Dorota Rowczenio,Maria Stensland,Gustavo A. de Souza,Erik H. Strøm,Janet A. Gilbertson,Graham W. Taylor,Nigel B. Rendell,Shane Minogue,Yvonne A. Efebera,Helen J. Lachmann,Ashutosh Wechalekar,Philip N. Hawkins,Ketil Heimdal,(unknown),(unknown),Nathalie Demoulin,Selda Aydın,Julian D. Gillmore,Tale Norbye Wien	23
13	Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue—a case series and genetic exploration 2016 ·Lara D. Veeken ·Dorota Rowczenio,Daniela Iancu,Hadija Trojer,Janet A. Gilbertson,Julian D. Gillmore,Ashutosh Wechalekar,Mehmet Tekman,Horia Stanescu,Robert Kleta,Thirusha Lane,Philip N. Hawkins,Helen J. Lachmann	43
14	A case report of hereditary apolipoprotein A-I amyloidosis associated with a novel APOA1 mutation and variable phenotype 2016 ·European Journal of Medical Genetics ·(unknown),Katja Venborg Pedersen,Søren Krag,Janet A. Gilbertson,Dorota Rowczenio,Julian D. Gillmore,Henrik Birn	15
15	Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study 2015 ·The Lancet Haematology ·Shameem Mahmood,Frank Bridoux,Christopher P. Venner,Sajitha Sachchithanantham,Janet A. Gilbertson,Dorota Rowczenio,Thomas Wagner,Rabya Sayed,Ketna Patel,Marianna Fontana,Carol Whelan,Helen J. Lachmann,Philip N. Hawkins,Julian D. Gillmore,Ashutosh Wechalekar	95
16	CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis 2014 ·JACC. Cardiovascular imaging ·Jason Dungu,Oswaldo Valencia,Jennifer H. Pinney,Simon Gibbs,Dorota Rowczenio,Janet A. Gilbertson,Helen J. Lachmann,Ashutosh Wechalekar,Julian D. Gillmore,Carol Whelan,Philip N. Hawkins,Lisa Anderson	235
17	Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient 2014 ·Journal of Neurology ·Peter McColgan,Steven F. Viegas,Sonia Gandhi,Kate Bull,(unknown),Farooq H. Sheikh,Jennifer H. Pinney,Marianna Fontana,Dorota Rowczenio,Julian D. Gillmore,Janet A. Gilbertson,CJ Whelan,(unknown),Zane Jaunmuktane,Janice L. Holton,Jonathan M. Schott,David J. Werring,Philip N. Hawkins,Mary M. Reilly	25
18	Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature 2013 ·Amyloid ·Michael Haidinger,Johannes Werzowa,Renate Kain,Marlies Antlanger,Manfred Hecking,Stefan Pfaffenberger,Julia Mascherbauer,Thomas Gremmel,Janet A. Gilbertson,Dorota Rowczenio,Thomas Weichhart,Chantal Kopecky,Walter H. Hörl,Philip N. Hawkins,Marcus D. Säemann	15
19	AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: A report of two cases 2006 ·Arthritis & Rheumatism ·Helen J. Lachmann,Hugh J. B. Goodman,Peter Andrews,Hugh Gallagher,James E. Marsh,(unknown),Dorota Rowczenio,A Bybee,Philip N. Hawkins	36
20	Autosomal dominant periodic fever with AA amyloidosis: Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family 2005 ·Journal of Nephrology ·Ayhan Dinç,Hakan Erdem,Dorota Rowczenio,İsmail Şimşek,Salih Pay,Muhterem Bahçe,Helen J. Lachmann	9

About Dorota Rowczenio

Dorota Rowczenio is a scholar working on Nephrology, Rheumatology and Molecular Biology, having authored 86 papers that have together received 3.8k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (59 papers), Inflammasome and immune disorders (24 papers) and Parathyroid Disorders and Treatments (21 papers). The work is most often cited by research in Nephrology (1.3k citations), Molecular Biology (3.3k citations) and Rheumatology (670 citations). Dorota Rowczenio has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Philip N. Hawkins, Helen J. Lachmann, Julian D. Gillmore, Janet A. Gilbertson, Ashutosh Wechalekar, Carol Whelan, Marianna Fontana, Simon Gibbs, Jennifer H. Pinney and Thirusha Lane. Their work appears in journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact